GERD: Clinical Trials

204 trials for GERD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

111 completed, 32 unknown, 21 recruiting, 20 terminated. 74 Not applicable, 26 Phase 4, 20 Phase 1, 15 Phase 3, 12 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable74Completed 29, Unknown 15, Recruiting 12, Terminated 8, Not yet recruiting 3, Withdrawn 3, Active not recruiting 2, Suspended 2
Phase 426Completed 17, Unknown 4, Recruiting 2, Withdrawn 2, Terminated 1
Phase 120Completed 15, Unknown 3, Recruiting 2
Phase 315Completed 12, Unknown 3
Phase 212Completed 7, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1
Early Phase 11Terminated 1

Follow GERD: new trials by email Literature Review of GERD trials Research Report on GERD

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endoscopic Band Ligation for Treating Reflux Disease
Band Ligation - GERD
Not applicableNot yet recruitingEl Katib Hospital102027-01-012026-09-10
PROPER-GERD: A Prospective Crossover Study to Evaluate Probe Placement Optimization for Reflux Testing in Women and Lower-BMI Patients
Bravo pH monitoring sessions - GERD
Not applicableNot yet recruitingUniversity of Chicago802026-12-012026-10-13
Antireflux Surgery Without Preoperative Esophageal Manometry
Preoperative workup without high-resolution esophageal manometry, Standard preoperative workup with high-resolution esophageal manometry - GERD, Hiatal Hernia
Not applicableNot yet recruitingMcMaster University962026-10-012026-08-10
Sedation Depth and EGJ Endoscopic Grading: A Randomized Controlled Trial
Upper gastrointestinal endoscopy - Gerd, Esophagogastric Junction
Not applicableCompletedMohamed Abd El-Raouf Tawfik1922026-06-012026-10-23
Pre- and Post-Therapy Evaluation of Air-Associated Symptoms in Patients With Gastro-esophageal Reflux Disease (GERD): Assessing the Role of Speech and Language Therapy
GERD
Enrolling by invitationProf Urs Zingg1002026-04-212026-06-11
Thread-Embedding Acupuncture as an Adjunct to Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease
Thread-Embedding Acupuncture - GERD, Gastroesophageal Reflux Disease
Not applicableRecruitingUniversity of Science Ho Chi Minh City502026-04-152026-09-01
PRospective Registry of Esophageal Motility
No intervention - Esophageal Diseases, Achalasia
RecruitingIRCCS San Raffaele100002026-03-092026-04-02
Diaphragmatic Training on GERD
Volume-oriented incentive spirometry, Diaphragmatic breathing exercise, Usual Care Group - GERD, Diaphragmatic Training
Not applicableRecruitingChanghua Christian Hospital422026-03-042026-04-22
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Vonoprazan, Esomeprazole 40mg - GERD
Not applicableRecruitingAsian Institute of Gastroenterology, India4142025-12-202026-03-06
Utility of Mucosal Impedance Device in Chronic Esophageal Disorders:
MuVI Esophageal mucosal impedance testing - Gerd, Eosinophilic Esophagitis
RecruitingMedical College of Wisconsin502025-11-202026-07-27
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Trimedat® - Irritable Bowel Syndrome, Gallstone Disease
Phase 1RecruitingValenta Pharm JSC362025-11-062026-02-19
Heartburn, Gastroesophageal Reflux Disease
Zastaprazan, Esomeprazole - GERD
Phase 4RecruitingIncheon St.Mary's Hospital1602025-07-072025-12-23
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
Vonoprazan, Esomeprazole 40mg - GERD
Not applicableRecruitingAsian Institute of Gastroenterology, India3002025-04-302026-04-27
Alginate vs Sucralfate for GERD Symptomatic Relief
Alginate, Sucralfate - GERD
Phase 2 / Phase 3CompletedCMH Lahore Medical College and Institute of Dentistry1402025-04-012026-07-15
Anti-Reflux Endoscopic Therapy Using Argon Plasma Coagulation (AREA) in Gastroesophageal Reflux Disease (GERD) Patients: A Single Center, Randomized, Sham, Controlled Trial (The AREA Study)
Anti reflux endoscopic theraphy, Endoscopy - GERD
Not applicableRecruitingAsian Institute of Gastroenterology, India182024-02-102025-02-12
Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)
GERD
UnknownAssiut University1002024-01-012024-06-13
Efficacy and Safety of Combined Thread Embedding Acupuncture With Auricular Acupuncture for GERD
Thread Embedding Acupuncture, Auricular acupuncture, Standard treatment - GERD
Not applicableCompletedUniversity of Medicine and Pharmacy at Ho Chi Minh City662023-12-062024-03-20
Famotidine and Antacids for Treatment of Dyspepsia
Intravenous Famotidine, Oral Maalox/ Mylanta - Dyspepsia, GERD
Phase 4RecruitingStony Brook University802023-11-092026-06-02
A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects
UI059, UIC202201 - GERD
Phase 1CompletedKorea United Pharm. Inc.82023-10-082023-11-21
Prospective Evaluation of PH-impedance Tracings According to the Wingate Consensus, and Influence on GERD Classification According to the Lyon Consensus
Questionnaires - GERD
RecruitingUniversitair Ziekenhuis Brussel1202023-09-292025-03-19

Showing 20 of 204. Sign in to see all of them.

Narrower conditions

Gastroesophageal Reflux (204)  ·  Heartburn (14)  ·  Barrett Esophagus (13)  ·  Obesity (12)  ·  Hernia, Hiatal (8)  ·  Obesity, Morbid (7)  ·  Esophagitis (6)  ·  Deglutition Disorders (5)  ·  Esophageal Achalasia (5)  ·  Esophagitis, Peptic (5)  ·  Gastroparesis (5)  ·  Non-Erosive Reflux Disease (5)  ·  Cough (4)  ·  Eosinophilic Esophagitis (4)  ·  Dyspepsia (3)

Broader conditions

Esophageal Motility Disorders (204)  ·  Digestive System Diseases (203)  ·  Gastrointestinal Diseases (203)  ·  Esophageal Diseases (202)  ·  Deglutition Disorders (199)  ·  Pathological Conditions, Signs and Symptoms (56)  ·  Signs and Symptoms (48)  ·  Nutritional and Metabolic Diseases (21)  ·  Nutrition Disorders (18)  ·  Overnutrition (18)  ·  Signs and Symptoms, Digestive (18)  ·  Body Weight (17)  ·  Overweight (17)  ·  Gastroenteritis (15)  ·  Stomach Diseases (15)

Interventions

Esomeprazole (28)  ·  Omeprazole (7)  ·  Pantoprazole (7)  ·  Endoscopy (6)  ·  Rabeprazole (6)  ·  Domperidone (5)  ·  Lansoprazole (5)  ·  1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine (3)  ·  Gastroscopy (3)  ·  Antacids (2)  ·  Baclofen (2)  ·  Citalopram (2)  ·  Endoscopy, Digestive System (2)  ·  Manometry (2)  ·  Acoustic Impedance Tests (1)

Sponsors

AstraZeneca (25)  ·  Mayo Clinic (8)  ·  Asian Institute of Gastroenterology, India (7)  ·  Chong Kun Dang Pharmaceutical (6)  ·  Johns Hopkins University (4)  ·  McMaster University (3)  ·  NDO Surgical, Inc. (3)  ·  Takeda (3)  ·  Torax Medical Incorporated (3)  ·  University of North Carolina, Chapel Hill (3)  ·  Assiut University (2)  ·  Baylor Research Institute (2)  ·  Capital Medical University (2)  ·  Children's Mercy Hospital Kansas City (2)  ·  Cinclus Pharma Holding AB (2)

Countries

United States (76)  ·  South Korea (14)  ·  Germany (10)  ·  Belgium (9)  ·  France (9)  ·  Italy (9)  ·  Canada (7)  ·  India (7)  ·  Switzerland (6)  ·  United Kingdom (6)  ·  Denmark (5)  ·  Hungary (5)  ·  Austria (4)  ·  Egypt (4)  ·  Netherlands (4)

Top investigators

Nicholas Shaheen, MD, MPH (3)  ·  Chuan Zhang, MD (2)  ·  Mohan Dr Ramchandani, MD DM (2)  ·  N van den Berk (2)  ·  Sergey Morozov, MD, PhD (2)  ·  A Sellink (1)  ·  A Sellink, MD (1)  ·  Adam M Tritsch, MD (1)  ·  Alain Castaigne, Medical Director (1)  ·  Aleksandar Nagorni, Prof. Dr (1)  ·  Amanda Cafaro, BSN (1)  ·  Amy Foxx-Orenstein, D.O. (1)  ·  Andres Maldonado, M.D. (1)  ·  Andrew Batey, M.D. (1)

Results publications

PMID 11275880, PMID 12872107, PMID 14595322, PMID 14745387, PMID 15647177, PMID 15855966, PMID 15855987, PMID 16542276, PMID 17116123, PMID 17391505, PMID 18443855, PMID 19601705, PMID 20110554, PMID 20578215, PMID 21083590, PMID 21083673, PMID 21242557, PMID 21347742, PMID 21586712, PMID 21952699, PMID 22111863, PMID 22642956, PMID 22759841, PMID 23560727, PMID 23622977, PMID 23800403, PMID 23840119, PMID 23919738, PMID 24018760, PMID 24151377, PMID 24299323, PMID 24976710, PMID 25171881, PMID 25304129, PMID 25330784, PMID 25448923, PMID 25858519, PMID 26559637, PMID 27712711, PMID 28119763, PMID 28567114, PMID 28607547, PMID 28894571, PMID 29248733, PMID 29739175, PMID 30257076, PMID 30504527, PMID 30625462, PMID 30711626, PMID 31564831

NIH funding

K23AT009218 (2), 2025 (1), K23DK115827 (1), R21DK077678 (1), R21DK097529 (1)